VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
JOHNSON, FAYE M
One or more keywords matched the following items that are connected to
JOHNSON, FAYE M
Item Type
Name
Concept
Proto-Oncogene Proteins B-raf
Concept
Proto-Oncogene Proteins c-bcl-2
Concept
Proto-Oncogene Proteins c-raf
Concept
Proto-Oncogene Proteins pp60(c-src)
Concept
Proto-Oncogene Proteins p21(ras)
Concept
Proto-Oncogene Proteins c-mdm2
Concept
Proto-Oncogene Proteins c-met
Concept
Proto-Oncogene Proteins
Concept
Proto-Oncogene Proteins c-kit
Concept
Proto-Oncogene Proteins c-akt
Academic Article
Combating resistance to anti-IGFR antibody by targeting the integrin ?3-Src pathway.
Academic Article
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.
Academic Article
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
Academic Article
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
Academic Article
Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer.
Academic Article
STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
Academic Article
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.
Academic Article
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras.
Academic Article
Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers.
Academic Article
Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
Academic Article
Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
Academic Article
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.
Academic Article
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Academic Article
Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.
Academic Article
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
Academic Article
Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers.
Academic Article
Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis.
Academic Article
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
Academic Article
Inhibition of nonsense-mediated decay rescues p53?/? isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
Academic Article
Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
Search Criteria
Proto Oncogene Proteins
pp60 c src